Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) Marketable Securities: ¥110.8 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920367 Jiangxi Xinganjiang Pharmaceutical Co Ltd BJSE:920367
68 GF Score
Price ¥25.38
GF Value ¥16.36
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Jiangxi Xinganjiang Pharmaceutical Co Marketable Securities?

Jiangxi Xinganjiang Pharmaceutical Co BJSE:920367 68 Marketable Securities is ¥110.8 Mil as of Jun. 2026. GuruFocus rates BJSE:920367 with a GF Score™ of 68/100 and a GF Value™ of ¥16.36 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Jiangxi Xinganjiang Pharmaceutical Co's Marketable Securities for the quarter that ended in Jun. 2026 was ¥110.8 Mil.

Jiangxi Xinganjiang Pharmaceutical Co's annual Marketable Securities declined from Dec. 2023 (¥175.4 Mil) to Dec. 2024 (¥149.8 Mil) but then increased from Dec. 2024 (¥149.8 Mil) to Dec. 2025 (¥190.9 Mil).

Jiangxi Xinganjiang Pharmaceutical Co  (BJSE:920367) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Jiangxi Xinganjiang Pharmaceutical Co Marketable Securities Related Terms

Jiangxi Xinganjiang Pharmaceutical Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for Jiangxi Xinganjiang Pharmaceutical Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangxi Xinganjiang Pharmaceutical Co Marketable Securities Chart

Jiangxi Xinganjiang Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 40.12 65.39 175.38 149.80 190.89

Jiangxi Xinganjiang Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 181.49 195.34 190.89 82.38 110.84
BJSE:920367
68GF Score
Jiangxi Xinganjiang Pharmaceutical Co Ltd BJSE:920367
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jiangxi Xinganjiang Pharmaceutical Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ¥110.8 Mil mean?
Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) has a Marketable Securities of ¥110.8 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Jiangxi Xinganjiang Pharmaceutical Co and its competitors.
Is Jiangxi Xinganjiang Pharmaceutical Co's Marketable Securities too high?
Jiangxi Xinganjiang Pharmaceutical Co's current Marketable Securities is ¥110.8 Mil. Overall, Jiangxi Xinganjiang Pharmaceutical Co has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jiangxi Xinganjiang Pharmaceutical Co's Marketable Securities compare to ZTS?
Jiangxi Xinganjiang Pharmaceutical Co's Marketable Securities of ¥110.8 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Jiangxi Xinganjiang Pharmaceutical Co and its competitors. Jiangxi Xinganjiang Pharmaceutical Co's current Marketable Securities is ¥110.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangxi Xinganjiang Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥16.36, compared to a current price of ¥25.38 — trading 55.1% above its estimated fair value. The current Marketable Securities is ¥110.8 Mil. Jiangxi Xinganjiang Pharmaceutical Co's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367), the current Marketable Securities is ¥110.8 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) Overvalued in 2026?

Based on GuruFocus' analysis, Jiangxi Xinganjiang Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥25.38 is trading 55.1% above its estimated GF Value™ of ¥16.36. GuruFocus considers Jiangxi Xinganjiang Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for BJSE:920367:

  • Marketable Securities: ¥110.8 Mil
  • GF Value™: ¥16.36 vs. price of ¥25.38 (55.1% above fair value)
  • GF Score™: 68/100 with 3 warning signs

No single metric tells the full story. See the BJSE:920367 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jiangxi Xinganjiang Pharmaceutical Co Business Description

Address No. 36 Yunzhang Road, Industrial Park, Jizhou District, Jiangxi Province, Ji'an City, CHN, 343000
Jiangxi Xinganjiang Pharmaceutical Co Ltd conducts research and development, production, and sales of chemical raw materials, chemical preparations, and Chinese patent medicines. The company's raw material medicine products are mainly calcium gluconate, zinc gluconate, ferrous gluconate, and other gluconate series raw material medicines. Its main chemical preparations are vitamin C chewable tablets and compound Yinqiao aminomin capsules, and Phenaminokamin Tablets.
68GF Score

Get the complete analysis for BJSE:920367

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥25.38
Price
¥16.36
GF Value